In the latest episode of the podcast, the Sharesify team discuss a mixed week of earnings updates and market reactions. Ian explains his absence from Wednesday’s recording. He reports back on a valuable evening of networking at the Association of investment Companies’ summer reception.
Steven discusses FTSE 100 tech specialist trust Polar Capital Technology (LON:PCT), which delivered another exceptionally strong year to 30 April 2026. He also highlights positive updates from Bytes Technology (LON:BYIT) and Computacenter (LON:CCC).
Next up, James explains why Hays’ (LON:HAS) upgrade owed plenty to cost-cutting and why the recruitment sector outlook is gloomy. And Ian tells us why negative drug trial news swiped billions from AstraZeneca’s (LON:AZN) stock market valuation in one fell swoop.
Finally, the chaps preview a busy week of earnings. US banks, Burberry (LON:BRBY) and Trustpilot (LON:TRST) are all prepping reports for investors.
Disclaimer: The author James Crux has a personal interest in Polar Capital Technology Trust.
Get involved
If you want to get involved, email us your thoughts, suggestions and questions at editorial@sharesify.com. For those tuning in via YouTube directly, please remember to click the like and subscribe buttons on our channel.
You can also follow us across social media, and if you’re a company, fund or investment trust, and you’d like to get your voice heard on the podcast, tell your story and expand your retail investor base, here’s your chance. Just email us at editorial@sharesify.com and we’ll do the rest.
